BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32572877)

  • 1. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
    Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
    Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
    Yang Y; Chen D; Liu H; Yang K
    Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0055538 regulates the malignant biological behavior of oral squamous cell carcinoma through the p53/Bcl-2/caspase signaling pathway.
    Su W; Sun S; Wang F; Shen Y; Yang H
    J Transl Med; 2019 Mar; 17(1):76. PubMed ID: 30857544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT/ERK
    Gao L; Dou ZC; Ren WH; Li SM; Liang X; Zhi KQ
    Cell Death Dis; 2019 Oct; 10(10):745. PubMed ID: 31582727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
    Fan QC; Tian H; Wang Y; Liu XB
    Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
    Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
    Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
    Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
    Gao WY; Yang G; Wang J; He JM; Wang P
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
    Ding N; Luo M; Liao XL; Bao QY; Li RY; Wu B
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6202-6210. PubMed ID: 31364120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
    Xu FY; Xu X; Hu XD
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.